Monday, June 27, 2011

Redwood Bioscience Gets Funding

Burlingame-based Redwood Bioscience, a firm focused on antibody-drug conjugates and peptide therapeutics, said today that it has secured new funding from Takeda Venturse. Amount of the funding was not disclosed. The firm said the funding will go to advance its site specific protein modification technology for enhancing antibody-drug conjugates and peptide therapeutics. Takeda Ventures is the corporate venture arm of Takeda Pharmaceutical Company Limited. More information »